Autopsy report · NCT02964962

REPRISE EDGE 29 mm EU Study

“Currently not moving forward with the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Boston Scientific Corporation

Sponsor type

Industry

Conditions

Aortic Valve Stenosis

Interventions

29 mm LOTUS Edge™ Valve System

Participants

0

Trials that died the same way

• CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
  “We decided to move on to another product and as a result will not be moving forward with this study.” (74% match in meaning)
• Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
  “Study never moved forward due to no accrual” (71% match in meaning)
• Percutaneous Ultrasonic Tenotomy Versus Platelet Rich Plasma for Gluteal Tendinopathy
  “Study not being pursued” (70% match in meaning)
• The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers
  “Study team decided not to move forward with study” (70% match in meaning)
• Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
  “Replaced with another study” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.